FDA REFORM BILL FOCUSING ON THIRD PARTY REVIEW PLANNED BY HOUSE "BLUE DOGS"; OVERSIGHT SUBCMTE. HEARING ON COMMISSIONER's OFFICE PLANNED FOR FEBRUARY
Executive Summary
An FDA reform proposal under development by the House Democratic "Blue Dog" coalition is understood to be focusing on third-party reviews.The coalition bill likely would avoid controversial elements such as permitting off-label information dissemination and imposing "hammers" if the agency failed to meet performance goals.